Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients

Acta Diabetologica

Volumn 40, Issue 4, 2003, Pages 151-155

  Arkkila, P E T ^a   Koskinen, P J ^b   Kantola, I M ^b   Ronnemaa T ^b   Seppanen E ^c   Viikari, J S A ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Deoxypyridinoline crosslinks; Limited joint mobility; N Telopeptides; Procollagen; Type I collagen; Type III collagen

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DEOXYPYRIDINOLINE; TELOPEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CROSS LINKING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GONIOMETRY; HUMAN; IMMOBILIZATION; INSULIN DEPENDENT DIABETES MELLITUS; JOINT LIMITATION; JOINT MOBILITY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGE OF ONSET; AGED; AMINO ACIDS; BIOLOGICAL MARKERS; COLLAGEN; COLLAGEN TYPE I; CREATININE; DIABETES MELLITUS, TYPE 1; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN;

EID: 0346734383     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-003-0104-0     Document Type: Article

References (21)

1. Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum M (1981) Limited joint mobility in childhood diabetes indicates increased risk for microvascular disease. N Engl J Med 305:191-194
2. Duffin AC, Donaghue KC, Potter M, McInnes A, Chan AK, King J, Howard NJ, Silink M (1999) Limited joint mobility in the hands and feet of adolescents with type 1 diabetes mellitus. Diabet Med 16:125-130
3. Buckingham BA, Uitto J, Sandborg C, Keens T, Kaufman F, Landing B (1981) Scleroderma-like syndrome and non-enzymatic glucosylation of collagen in children with poorly controlled insulin dependent diabetes (IDDM). Pediatr Res 15:626 (abstract)
4. Fisher L, Kurtz A, Shipley M (1986) Association between cheiroarthropathy and frozen shoulder in patients with insulin-dependent diabetes mellitus. Br J Rheumatol 25:141-146
5. Seibold JR, Uitto J, Dorwart BB, Prockop DJ (1985) Collagen synthesis and collagenase activity in dermal fibroblasts from patients with diabetes and digital sclerosis. J Lab Clin Med 105:664-667
6. Buckingham B, Reiser KM (1990) Relationship between the content of lysyl oxidase-dependent cross-links in skin collagen, nonenzymatic glycosylation, and long-term complications in type I diabetes mellitus. J Clin Invest 86:1046-1054
7. Bornstein P, Sage H (1980) Structurally distinct collagen types Ann Rev Biochem 49:957-1003
8. Uitto J, Ryhänen L, Tan EML (1981) Collagen: its structure, function, and pathology. In: Fleischmajer R (ed) Progress in disease of the skin, vol. 1. Grune Stratton, New York, pp 103-141
9. Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP, Risteli L (1988) Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem 34:715-718
10. Melkko J, Niemi S, Risteli L, Risteli J (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328-1332
11. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39:635-640
12. Hanson DA, Weiss Me, Bollen A-M, Masalan SL, Singer FR, Eyre DR (1992) A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1252-1258
13. Schmidt-Gayk H, Roth HJ, Becker S, Reichel H, Boneth HG, Knuth UA (1995) Noninvasive parameters of bone metabolism. Curr Opin Nephrol Hypertens 4:334-338
14. Dixon WJ (ed) (1990) BMDP statistical software. University of California, Los Angeles
15. 1C as markers of diabetic complications. Diabetes 48:870-880
16. Okazaki R, Matusuoka K, Horiuchi A, Maruyama K, Okazaki I (1988) Assays of serum laminin and type III procollagen peptide for monitoring the clinical course of diabetic microangiopathy. Diab Res Clin Pract 5:163-170
17. Heickendorff L, Parvez A, Bjerring P, Halkier-Sorensen L, Zachariae H (1991) Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up-investigation in subclasses and during therapy. Acta Derm Venereol 71:185-188
18. Brink SJ (1987) Limited joint mobility as a risk factor for diabetes complications. Clin Diabetes 5:122-127
19. Sondergaard K, Heickendorff L, Risteli L, Risteli J, Zachariae H, Stengaard-Pedersen K, Deleuran B (1997) Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br J Dermatol 136:47-53
20. Rosenbloom AL, Silverstein JH, Lezotte DC, Riley WJ, Maclaren NK (1982) Limited joint mobility in diabetes mellitus of childhood: natural history and relationship to growth impairment. J Pediatr 101:874-878
21. Rosenbloom AL (1989) Limitation of finger joint mobility in diabetes mellitus. J Diabetes Complications 3:77-87